Streetbeat News

Earnings

AMD

Financial analysts have observed a significant bearish trend in options trading for Advanced Micro Devices (NASDAQ:AMD), with a slight majority of traders showing bearish tendencies. Despite this, the volume and open interest in AMD's options suggest a target price range of $180.0 to $220.0. Recent analyst ratings have varied, with a consensus target price of $216.0, though opinions range from cautious downgrades to optimistic buys. AMD's current stock performance is stable, with an upcoming earnings announcement in 33 days.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 2:00 pm

COCP

Cocrystal Pharma (NASDAQ:COCP) reported Q4 earnings, beating estimates with an EPS of $-0.44 against an expected $-0.6. However, revenue remained unchanged from the previous year. The company had previously beaten EPS estimates last quarter, which led to no change in share price the following day.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 1:50 pm

COIN

Investors have shown a bullish stance on Coinbase Global (NASDAQ:COIN), with a significant amount of money moving into options for the stock. Benzinga's options scanner revealed 8 notable trades, indicating a split sentiment with 62% bullish and 37% bearish. The trades target a price range of $250 to $470 for COIN over the next 3 months. The largest trades were bullish calls, with the highest being a $324K call for a strike price of $300. COIN's current price is $260.21, up 1.37%, with an RSI suggesting it may be approaching overbought territory. Earnings are expected in 35 days.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 1:46 pm

CADL

Candel Therapeutics (NASDAQ:CADL) reported Q4 earnings with an EPS of $-0.38, missing estimates by -138.0% compared to the expected $-0.16. Revenue decreased by $31 thousand from the same period last year. Despite missing EPS estimates last quarter followed by a 4.0% share price increase the next day, this quarter's performance may concern investors.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 1:40 pm

ATRA

Atara Biotherapeutics (NASDAQ:ATRA) reported Q4 earnings with an EPS of $-0.56, missing estimates by -17.0% against an expected $-0.48. Revenue increased by $4.03 million year-over-year. The company's past earnings performance shows a pattern of missing EPS estimates, which previously led to a 6.0% drop in share price the following day.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 1:35 pm

AZUL

Azul (NYSE:AZUL) reported Q4 adjusted losses of $(0.47) per share, missing the analyst consensus estimate of $0.14. However, their quarterly sales of $1.01 billion exceeded the estimate of $985.30 million. This represents a 53% decrease in losses and a 19.79% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 1:33 pm

LUNR

Intuitive Machines Inc (NASDAQ:LUNR) shares are trading lower after the company filed a prospectus for an offering of up to $300 million of its common stock. The filing includes an offering of 159,808,031 shares and 8.295 million warrants. Despite a recent rally due to its successful moon landing mission, the stock is down 4.36% at $6.58. The company reported $4.5 million in cash and $54.6 million including warrant exercises as of March 1.

Portfolio Pulse from Adam Eckert

March 28, 2024 | 1:29 pm

CAAS

China Automotive Systems, Inc (NASDAQ:CAAS) reported a significant increase in its fourth-quarter FY23 sales, with a 23.6% growth year-on-year to $159.20 million. The company's gross profit margin expanded by 240 basis points to 21.8%, and its gross profit rose by 38.8% to $34.7 million. Operating income for the quarter was $13.6 million, compared to an operating loss of $(2.6) million in the same quarter of the previous year. Net income attributable to common shareholders increased by 153.5% to $10.9 million. The company expects FY24 revenue of $605 million, above the estimate of $593.11 million. CAAS shares surged 7.12% to $3.61 in premarket trading.

Portfolio Pulse from Shivani Kumaresan

March 28, 2024 | 1:28 pm

IVVD

Invivyd (NASDAQ:IVVD) reported Q4 earnings with a significant miss on estimated earnings by -60.0%, posting an EPS of $-0.67 against an estimate of $-0.42. Revenue remained unchanged from the same period last year. In the previous quarter, the company had beaten EPS estimates, which led to no change in share price the following day.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 1:25 pm

DLNG

Dynagas LNG Partners (NYSE:DLNG) reported Q4 earnings with an EPS of $0.2, missing estimates by -33.0% against an expected $0.3. Revenue increased by $1.89 million year-over-year. Despite missing last quarter's EPS estimate, the share price increased by 3.0% the following day. Historical earnings show a pattern of missed EPS estimates but increased revenues.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 1:20 pm